» Articles » PMID: 37297541

HIV and Hepatitis C Risk Among Tajik Migrant Workers Who Inject Drugs in Moscow

Overview
Publisher MDPI
Date 2023 Jun 10
PMID 37297541
Authors
Affiliations
Soon will be listed here.
Abstract

The human immunodeficiency virus (HIV) epidemic in Eastern Europe and Central Asia continues to grow with most infections occurring in high-risk groups including people who inject drugs and their sexual partners. Labor migrants from this region who inject drugs while in Russia are at especially high HIV risk. Male Tajik migrant workers who inject drugs in Moscow (N = 420) were interviewed prior to a randomized trial of the Migrants' Approached Self-Learning Intervention in HIV/AIDS (MASLIHAT) peer-education HIV-prevention intervention. Participants were interviewed about their sex and drug use behavior and tested for HIV and hepatitis C (HCV) prior to the intervention. Only 17% had ever been tested for HIV. Over half of the men reported injecting with a previously used syringe in the past month, and substantial proportions reported risky sexual behavior. Prevalence rates of HIV (6.8%) and HCV (2.9%) were elevated, although lower than expected when compared to estimates of prevalence among people who inject drugs at the national level in Tajikistan. Risk behavior in diaspora varied across the men's regional area of origin in Tajikistan and occupation in Moscow, with HIV prevalence rates highest among those working at the bazaars. Evidence-based prevention approaches and messaging that specifically address the drug- and sex-related risk behavior of migrants with varying backgrounds are needed.

Citing Articles

Inclusion of Labor Migrants as a Potential Key Population for HIV: A Nationwide Study from Tajikistan.

Kwan B, Torabzadeh H, Akinwalere A, Nguyen J, Cortez P, Abdullozoda J Trop Med Infect Dis. 2024; 9(12).

PMID: 39728831 PMC: 11679146. DOI: 10.3390/tropicalmed9120304.


Peer Education Intervention Reduced Sexually Transmitted Infections Among Male Tajik Labor Migrants Who Inject Drugs: Results of a Cluster-randomized Controlled Trial.

Mackesy-Amiti M, Levy J, Luc C, Jonbekov J medRxiv. 2024; .

PMID: 39185538 PMC: 11343258. DOI: 10.1101/2024.08.15.24312070.


Changes in risk behaviour following a network peer education intervention for HIV prevention among male Tajik migrants who inject drugs in Moscow: a cluster-randomized controlled trial.

Mackesy-Amiti M, Bahromov M, Levy J, Jonbekov J, Luc C J Int AIDS Soc. 2024; 27 Suppl 3:e26310.

PMID: 39030891 PMC: 11258451. DOI: 10.1002/jia2.26310.

References
1.
Bromberg D, Tate M, Alaei K, Karimov S, Saidi D, Alaei A . Association between time spent in the Russian Federation and late presentation for HIV among Tajikistani migrants. BMC Public Health. 2020; 20(1):1379. PMC: 7488340. DOI: 10.1186/s12889-020-09434-6. View

2.
Ingabire P, Semitala F, Kamya M, Nakanjako D . Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90% of HIV-Infected Individuals. AIDS Res Treat. 2019; 2019:1832152. PMC: 6463639. DOI: 10.1155/2019/1832152. View

3.
Guerra-Ordonez J, Benavides-Torres R, Zapata-Garibay R, Ruiz-Cerino J, Avila-Alpirez H, Salazar-Barajas M . [HIV risk perception and safe sex in migrants from the northern border of Mexico]. Rev Int Androl. 2022; 20(2):80-85. DOI: 10.1016/j.androl.2020.10.010. View

4.
Kashnitsky D, Richter J . 'In Short, We Will Deport You': Disrupted temporalities of migrants with HIV in Russia. Glob Public Health. 2021; 17(11):2841-2853. DOI: 10.1080/17441692.2021.2002923. View

5.
Guillon M, Celse M, Geoffard P . Economic and public health consequences of delayed access to medical care for migrants living with HIV in France. Eur J Health Econ. 2017; 19(3):327-340. DOI: 10.1007/s10198-017-0886-6. View